Prevalence of germline BRCA mutations in HER2-negative metastatic breast cancer: global results from the real-world, observational BREAKOUT study - O’Shaughnessy, J; Brezden-Masley, C; Cazzaniga, M (Breast cancer research, 2020)
et al.